Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences.
about
Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantationClinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort StudyThe impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.Viral surveillance and subclinical viral infection in pediatric kidney transplantation.Peripheral Blood Epstein-Barr Viral Nucleic Acid Surveillance as a Marker for Posttransplant Cancer Risk.Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.Epstein-Barr virus infection in adult renal transplant recipients.The Epstein-Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells.The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children.Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study.Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation.Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.Monitoring of intracellular adenosine triphosphate in CD4(+) T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients.Detection of Epstein-Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications.Cytomegalovirus & Epstein Barr Virus serostatus as a predictor of the long-term outcome of kidney transplantation.The role of CMV and EBV renal allograft loss--reply.The role of CMV and EBV in renal allograft loss.BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study
P2860
Q26998832-2D57BDEA-4DF2-43CD-ADC2-9EF670323A22Q33874038-008373E7-B559-4C30-80D9-7939ACE8FB6EQ35106937-06C67351-112B-4BBD-A464-3F27E59E9664Q38240085-5399DBC5-1072-41FF-8579-FF6DE85E421CQ38908687-A6D19AB8-72FA-4ECE-9BAC-5B93706255C4Q39091657-00BA551B-CAE2-4E9F-8125-15AAB165989BQ39194877-BDEC7EA1-B55A-4E8A-9D29-86D6CAEDC94CQ39311630-9954C1D6-9EF5-42DE-89AE-969050A5FBCEQ39321579-125A0995-6D9A-4B5B-BDD6-40DF183669AAQ39386528-45411C76-573A-41C3-8821-8D1B83190FDDQ40358580-2F0858E5-0565-449F-B8F0-CC49F6225A5DQ40628228-D982EB83-4BCB-4A91-BDBD-3F285E1C494BQ40630330-F5E1247F-6C1E-4AEE-A2FF-7F2CB200C1D0Q40721769-E4928971-EEB6-4A3C-8BFE-E07312C4C1B1Q42278126-E117D7E9-2009-4DAF-88B3-DF9EB73858D5Q51869720-FFE97E25-A685-4421-9A38-4422E95DA1EAQ51870875-7BB44AC6-8FE0-418D-ACFB-9D964450F2EFQ56957209-9A4DED81-FAE4-4BE5-A1F7-60BC4BFAEE49
P2860
Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Subclinical Epstein-Barr virus ...... s: incidence and consequences.
@en
Subclinical Epstein-Barr virus ...... s: incidence and consequences.
@nl
type
label
Subclinical Epstein-Barr virus ...... s: incidence and consequences.
@en
Subclinical Epstein-Barr virus ...... s: incidence and consequences.
@nl
prefLabel
Subclinical Epstein-Barr virus ...... s: incidence and consequences.
@en
Subclinical Epstein-Barr virus ...... s: incidence and consequences.
@nl
P2093
P2860
P356
P1476
Subclinical Epstein-Barr virus ...... s: incidence and consequences.
@en
P2093
A Coaquette
C Courivaud
J Bamoulid
J-M Chalopin
P2860
P304
P356
10.1111/AJT.12009
P407
P577
2013-01-17T00:00:00Z